Investing
AstraZeneca signs $2 billion agreement with Quell to develop cell therapies
© Reuters. FILE PHOTO: FILE PHOTO: Test tubes are seen in front of a displayed AstraZeneca logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration
(Reuters) – AstraZeneca (NASDAQ:) said on Friday it had signed an agreement with Quell Therapeutics potentially worth more than $2 billion to develop cell therapies that could cure autoimmune diseases.
The agreement includes developing, manufacturing and commercialising cell therapies that have the potential to be curative in type 1 diabetes and inflammatory bowel disease indications, the drugmaker said in a statement.
UK-based Quell will receive $85 million upfront from AstraZeneca, and is also eligible to receive over $2 billion for further development and commercialisation milestones, the company added.
Read the full article here
How to Make Money with Print on Demand: A Step-by-Step Guide
Billionaire Robert Hale Jr Gives $1,000 in Cash to Graduates
Why Product Managers Hold the Key to Ethical AI Success
Jeff Bezos’ Miami Neighbors Are Selling Their Land for $200M
How Anyone, Anywhere Can Launch a Startup in the Age of AI
Expand Your Global Reach with Access to More Than 150 Languages for Life
KFC Announces Saucy, a Chicken Tenders-Focused Spinoff
This AI is the Key to Unlocking Explosive Sales Growth in 2025
Palantir, Anduril join forces with tech groups to bid for Pentagon contracts, FT reports By Reuters
4 Ways Content Can Make or Break the Customer Experience
Debt ceiling debate and its effect on the U.S. dollar
Debt ceiling default: Still no deal between parties
Stovall: If the U.S. defaults on its debt, all S&P 500 sectors will likely fall
What China's weaker-than-expected economy could mean for U.S. markets
A ‘Big Short’ investor sees financial disaster brewing in housing markets — again
-
Side Hustles7 days agoExpand Your Global Reach with Access to More Than 150 Languages for Life
-
Side Hustles6 days agoKFC Announces Saucy, a Chicken Tenders-Focused Spinoff
-
Side Hustles7 days agoThis AI is the Key to Unlocking Explosive Sales Growth in 2025
-
Investing6 days agoPalantir, Anduril join forces with tech groups to bid for Pentagon contracts, FT reports By Reuters
-
Side Hustles5 days ago4 Ways Content Can Make or Break the Customer Experience
-
Side Hustles5 days agoHow to Build a Legacy of Leadership in Your Business in Six Proven Strategies
-
Investing7 days ago14 lessons from 2024 to remember in 2025: BofA By Investing.com
-
Passive Income3 days agoWhy Emotional Intelligence Is the Key to High-Impact Leadership